AI-powered Viz SDH automatically detects subdural hemorrhage, enables effective triage and optimal care SAN FRANCISCO–(BUSINESS WIRE)–Insert after fourth paragraph of release: footnote 2. The updated release reads: VIZ.AI RECEIVES FDA 510(K) CLEARANCE FOR VIZ SDH AI-powered Viz SDH automatically detects subdural hemorrhage, enables effective triage and optimal care Viz.ai, the […]
Tag: Viz.Ai
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®. Together, they will bring MRI to the patient’s bedside and deliver valuable insights to the clinician’s fingertips for timely […]
Viz.ai Receives FDA 510(k) Clearance for Viz ANEURYSM
First AI-powered cerebral aneurysm detection solution designed to facilitate population screening and enhanced care management SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM. The new algorithm uses AI to […]
Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
SAN FRANCISCO & ORLANDO, Fla.–(BUSINESS WIRE)–Viz.ai – the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at the 48th annual VEITHsymposium November 16 – 20 in Orlando, Fla., the new modules allow for faster clinical decision making and improved […]
Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease
SAN FRANCISCO & PARIS–(BUSINESS WIRE)–Viz.ai, the world leader in AI-driven intelligent care coordination, has partnered with Avicenna.AI, a global leader in artificial intelligence solutions, to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. The collaboration will pave the way for faster […]
FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients. A stroke is a serious medical condition that requires emergency care […]